Results 211 to 220 of about 178,738 (259)
Association between clopidogrel use and improved survival in critically ill patients with acute kidney injury: insights from MIMIC-IV database. [PDF]
BMC NephrolZhu Y +7 more
europepmc +1 more source
A Critical Review of the Molecular and Clinical Effects of Cilostazol After Percutaneous Coronary Intervention. [PDF]
J Cardiovasc Dev DisFerrari R, Perrone Filardi P.
europepmc +1 more source
A case report: reflections on the formation of acute thrombotic events after PCI in patients with acute ST-Segment elevation myocardial infarction. [PDF]
Int J Emerg MedYang J, Yang J, Huang H, Wei J, Tang P.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 1997
Clopidogrel is a thienopyridine that irreversibly inhibits platelet aggregation by selectively binding to adenylate cyclase-coupled ADP receptors on the platelet surface. In animal models, clopidogrel reduced the formation of both arterial and venous thrombi.
A J, Coukell, A, Markham
openaire +3 more sources
Clopidogrel is a thienopyridine that irreversibly inhibits platelet aggregation by selectively binding to adenylate cyclase-coupled ADP receptors on the platelet surface. In animal models, clopidogrel reduced the formation of both arterial and venous thrombi.
A J, Coukell, A, Markham
openaire +3 more sources
American Journal of Therapeutics, 2010
Clopidogrel resistance is an emerging clinical scenario, as antiplatelet therapy has become the cornerstone of modern cardiovascular treatment. This leads to an increase in stent thromboses and recurrent ischemic events which add to the health care costs, and increased periprocedural morbidity and mortality.
Jaya Prakash, Sugunaraj +4 more
openaire +2 more sources
Clopidogrel resistance is an emerging clinical scenario, as antiplatelet therapy has become the cornerstone of modern cardiovascular treatment. This leads to an increase in stent thromboses and recurrent ischemic events which add to the health care costs, and increased periprocedural morbidity and mortality.
Jaya Prakash, Sugunaraj +4 more
openaire +2 more sources
Heart, Lung and Circulation, 2007
Clopidogrel resistance has been used as one of the terms employed in the literature to describe different degrees of ex vivo low platelet inhibition after clopidogrel administration. In addition to the diverse nomenclature, the characterisation of clopidogrel resistance has also been problematic because different authors have given different ...
Ernesto, Oqueli +2 more
openaire +2 more sources
Clopidogrel resistance has been used as one of the terms employed in the literature to describe different degrees of ex vivo low platelet inhibition after clopidogrel administration. In addition to the diverse nomenclature, the characterisation of clopidogrel resistance has also been problematic because different authors have given different ...
Ernesto, Oqueli +2 more
openaire +2 more sources